ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Mallinckrodt plc Investors with losses in Excess of 100K to Secure Counsel Before Important Deadline in Securities Class Action - MNK, MNKPF - Marketscreener.com

NUNZ Stock  USD 0  0.00  0.00%   
Slightly above 67% of Nunzia Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Nunzia Pharmaceutical pink sheet suggests that many investors are alarmed at this time. Nunzia Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, Nunzia Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
  
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Mallinckrodt plc Investors with losses in Excess of 100K to Secure Counsel Before Important Deadline in Securities Class Action - MNK, MNKPF Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

Nunzia Pharmaceutical Fundamental Analysis

We analyze Nunzia Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nunzia Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nunzia Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash And Equivalents

Cash And Equivalents Comparative Analysis

Nunzia Pharmaceutical is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Peers

Trending Equities

AAPL  0.94   
0%
19.0%
T  0.82   
0%
16.0%
CVX  0.65   
0%
13.0%
MET  0.48   
0%
9.0%
C  0.13   
0%
2.0%
HD  0.34   
6.0%
0%
S  0.50   
10.0%
0%
WFC  1.03   
21.0%
0%
AAL  1.16   
23.0%
0%
IBM  1.65   
33.0%
0%
CVS  1.78   
36.0%
0%
UPS  1.88   
38.0%
0%
TGT  3.05   
62.0%
0%
INTC  3.28   
67.0%
0%
AA  3.42   
69.0%
0%
BBY  4.89   
100.0%
0%

Additional Tools for Nunzia Pink Sheet Analysis

When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.